CAW
ABBV icon

Cornerstone Advisors (Washington)’s AbbVie ABBV Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,719
Closed -$416K – 756
2019
Q2 		$416K Buy
5,719
+454
+9% +$35.7K 0.04% 68
2019
Q1 		$424K Buy
5,265
+403
+8% +$33K 0.04% 64
2018
Q4 		$448K Buy
4,862
+466
+11% +$41K 0.08% 54
2018
Q3 		$416K Buy
4,396
+178
+4% +$16.9K 0.27% 57
2018
Q2 		$391K Buy
4,218
+1,321
+46% +$129K 0.27% 64
2018
Q1 		$274K Buy
2,897
+4
+0.1% +$439 0.19% 78
2017
Q4 		$280K Buy
2,893
+100
+4% +$9.43K 0.19% 78
2017
Q3 		$248K Hold
2,793
– – 0.17% 84
2017
Q2 		$203K Hold
2,793
– – 0.11% 101
2017
Q1 		$182K Sell
2,793
-11
-0.4% -$692 0.1% 106
2016
Q4 		$176K Buy
2,804
+123
+5% +$7.51K 0.15% 102
2016
Q3 		$169K Hold
2,681
– – 0.14% 95
2016
Q2 		$166K Sell
2,681
-461
-15% -$28.1K 0.17% 68
2016
Q1 		$179K Buy
3,142
+2,740
+682% +$153K 0.19% 68
2015
Q4 		$24K Buy
402
+53
+15% +$3.05K 0.03% 282
2015
Q3 		$19K Sell
349
-12
-3% -$781 0.02% 324
2015
Q2 		$24K Buy
361
+50
+16% +$3.26K 0.02% 226
2015
Q1 		$18K Sell
311
-70
-18% -$4.23K 0.01% 293
2014
Q4 		$25K Buy
381
+70
+23% +$4.41K 0.02% 244
2014
Q3 		$18K Sell
311
-28
-8% -$1.55K 0.01% 140
2014
Q2 		$19K Hold
339
– – 0.02% 148
2014
Q1 		$17K Buy
+339
New +$17.1K 0.02% 146

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cornerstone Advisors (Washington)'s ABBV Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of AbbVie (ABBV) in Q3 2019, closing a stake of 5,719 shares — an estimated $416K sold.

Cornerstone Advisors (Washington) first reported a position in ABBV in Q1 2014 and held it in 22 quarters. The position peaked at $448K in Q4 2018. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining AbbVie position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 5,719 AbbVie shares in Q3 2019, an estimated $416K.
  • Cornerstone Advisors (Washington) first reported a position in AbbVie in Q1 2014 and held it in 22 quarters.
  • Cornerstone Advisors (Washington)'s AbbVie position peaked at $448K in Q4 2018.
  • 2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.